Astera Labs (ALAB) has put up another active quarter, with Q1 2026 revenue of US$308.4 million and basic EPS of US$0.47, at a time when trailing 12 month EPS sits at US$1.59 on revenue of about US$1.0 billion and net income of US$267.6 million. This comes alongside very large year on year earnings growth and higher profit margins over the past year. Over the last five reported quarters, revenue has moved from US$159.4 million in Q1 2025 to US$308.4 million in Q1 2026, while quarterly EPS has ranged between US$0.19 and US$0.54. Taken together, these figures present a picture of expanding profitability that puts margins at the center of the latest print.

See our full analysis for Astera Labs.

With the headline numbers on the table, the next step is to see how this margin story lines up with the widely held narratives around Astera Labs and where those narratives might need a rethink.

TTM earnings near US$268 million with margins at 26.7%

• Over the last 12 months, Astera Labs generated about US$1.0b in revenue and US$267.6 million in net income, which works out to a 26.7% net margin compared with 8.4% the prior year.
• What stands out for the bullish view is how this very large earnings growth over the last year and higher net margin sit alongside trailing EPS of US$1.59. Bulls see this as evidence of strong operating leverage, yet:
  • the same data shows earnings growing at a very high rate from a smaller base, so future periods will need to absorb much larger absolute profit dollars to keep that story intact, and
  • the current margin level also has to be weighed against risks in the bullish narrative such as heavy dependence on hyperscale AI infrastructure demand and ongoing high R&D spend, both of which could influence how sustainable a 20%+ net margin really is if conditions change.

Bulls argue that this combination of high recent earnings growth and a 26.7% net margin points to a business that could support premium profitability over time. The numbers also show how sensitive that case is to maintaining high AI infrastructure demand and product attach rates across Scorpio, Leo and other lines 🐂 Astera Labs Bull Case

Valuation premium versus 136.9x trailing P/E

• The stock is referenced on a trailing P/E of about 136.9x compared with a peer average of 70.9x and a semiconductor industry average of 48.5x, while the DCF fair value of US$112.56 sits well below the current share price of US$213.91.
• Bears focus on this valuation gap and argue that even with strong recent performance, there is little room for error. This view lines up with:
  • analyst expectations that earnings and revenue will grow faster than the broader US market, meaning a lot of that upside already appears embedded in the current multiple, and
  • the fact that the DCF fair value is just over half of the current share price, which challenges the idea in bullish and consensus narratives that high growth alone fully supports pricing that is well above both peer and industry P/E levels.

For a beginner investor, the key takeaway is that the market is attaching a much higher multiple to Astera Labs than to many semiconductor peers, and that difference is clearly visible when you put the 136.9x trailing P/E next to the DCF fair value of US$112.56.

Rapid revenue scale to about US$1.0b TTM

• Looking across the last six reported quarters, revenue has moved from US$141.1 million in Q4 2024 to US$308.4 million in Q1 2026, which contributes to trailing 12 month revenue of about US$1.0b alongside trailing basic EPS of US$1.59.
• Consensus narrative points to diversified product adoption and strong industry partnerships as key supports for this revenue scale. The reported numbers give that view some backing while also showing the concentration of expectations:
  • quarterly net income moved from US$24.7 million in Q4 2024 to US$80.3 million in Q1 2026, which is consistent with the idea that higher attach rates and broader deployments across PCIe, CXL and related products are feeding into higher profit dollars, and
  • at the same time, the forecasts in the analysis data call for earnings growth of about 31.5% a year and revenue growth of about 25.9% a year, so the consensus view is already building this rapid scaling into its long term story and leaves less room for disappointment if growth settles closer to overall market benchmarks.

Skeptics warn that such fast scaling and ambitious growth forecasts mean investors should keep a close eye on how quarterly revenue and net income track against these expectations, especially given the company’s focus on AI data center connectivity and the higher volatility in the share price over recent months 🐻 Astera Labs Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Astera Labs on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With this mix of optimism and concern around Astera Labs already on the table, it helps to move quickly from headline narratives to the underlying data and stress test what matters most for your own portfolio. To see how the potential upsides stack up against the key issues investors are watching, take a close look at the 2 key rewards and 2 important warning signs

See What Else Is Out There

Astera Labs carries a very high 136.9x trailing P/E and a DCF fair value of US$112.56 that sits well below the current share price.

If that kind of valuation risk makes you uneasy, it is worth balancing your watchlist with stocks screened as 45 high quality undervalued stocks so you are actively hunting for ideas where price and fundamentals line up more tightly.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.